Literature DB >> 11123104

Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis.

J Chesney1, R Bucala.   

Abstract

Peripheral blood fibrocytes are a novel population of cells that rapidly enter sites of tissue injury and contribute to connective scar formation. Fibrocytes display a distinct cell surface phenotype (CD34+/CD45+/collagen I+), and are an abundant source of cytokines and growth factors that function to attract and activate inflammatory and connective tissue cells. Fibrocytes also are specialized to activate naïve T cells against foreign antigen, and may play a critical role in the initiation of cognate immunity during the earliest phases of tissue injury. Recently, immunohistochemical studies of fibrotic tissues have shown that fibrocytes co-localize to areas of connective tissue matrix deposition. Peripheral blood fibrocytes thus may participate in the generation of excessive fibroses associated with various autoimmune disorders involving a persistent T-cell activation, as occurs in scleroderma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123104     DOI: 10.1007/s11926-000-0027-5

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  26 in total

1.  Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes.

Authors:  J Chesney; C Metz; A B Stavitsky; M Bacher; R Bucala
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

2.  Antibodies to topoisomerase I in sera from patients with scleroderma.

Authors:  J H Shero; B Bordwell; N F Rothfield; W C Earnshaw
Journal:  J Rheumatol Suppl       Date:  1987-06

3.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders.

Authors:  I C Le Poole; T Mutis; R M van den Wijngaard; W Westerhof; T Ottenhoff; R R de Vries; P K Das
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

5.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

6.  Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.

Authors:  P C Evans; N Lambert; S Maloney; D E Furst; J M Moore; J L Nelson
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

7.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset.

Authors:  A Galy; M Travis; D Cen; B Chen
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

8.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.

Authors:  T J Schall; K Bacon; R D Camp; J W Kaspari; D V Goeddel
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.

Authors:  K Inaba; J P Metlay; M T Crowley; R M Steinman
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

View more
  34 in total

1.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 2.  One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.

Authors:  Darwin J Prockop; Carl A Gregory; Jeffery L Spees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4(+) T cells.

Authors:  Abelardo Medina; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

4.  CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.

Authors:  Bethany B Moore; Jill E Kolodsick; Victor J Thannickal; Kenneth Cooke; Thomas A Moore; Cory Hogaboam; Carol A Wilke; Galen B Toews
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 5.  Stem cells in airway smooth muscle: state of the art.

Authors:  Jaime Murphy; Ross Summer; Alan Fine
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

Review 6.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 7.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

8.  Osteogenic and adipogenic differentiation potential of an immortalized fibroblast-like cell line derived from porcine peripheral blood.

Authors:  Xiuqing Wang; Daphne Moutsoglou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

9.  Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

Authors:  Erin F Gillespie; Nupur Raychaudhuri; Konstantinos I Papageorgiou; Stephen J Atkins; Ying Lu; Laya K Charara; Tünde Mester; Terry J Smith; Raymond S Douglas
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-21       Impact factor: 4.799

10.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.